RESI Boston, Sept. 21-23
RESI connects start-ups, early-stage investors, and strategic channel partners maximizing fit for each technology and each company’s stage of development.
This author has not written his bio yet.
But we are proud to say that Ayal Ronen contributed 231 entries already.
RESI connects start-ups, early-stage investors, and strategic channel partners maximizing fit for each technology and each company’s stage of development.
As a leading European partnering event, with 700+ participants from 30+ countries, MedFIT helps industry players find early-stage assets…
senior executive conference advancing healthcare by connecting leaders in science and industry with investors and strategic partners
How to Deliver Safe and Effective Adoptive Cell Therapy Products to Clinical Promise, Commercial Scale Manufacturing and Patients
The event brings together leaders from cancer research institutes, patient advocacy groups, early and late-stage investors, pharmas, & biotechs. 300+, 20+ company presentations, 50+% attendees are corporate and financial investors, analysts, bankers and advisors.
Your opportunity to connect with investors and strategic partners, Digital RESI June focuses on early-stage funding for all life science verticals: drugs, devices, diagnostics, digital health.
LSX is an community of senior life science & healthcare decision-makers that develops connections with the capital and partners we need to grow our businesses.
NCI and CDMRP are awarding over $7 BILLION in funding for cancer R&D. To learn more, listen to our free webinar about these opportunities.
Find out about more than $7 Billion In Funding Opportunities for Cancer Research – and our webinar all about them
The Peer Reviewed Cancer Research Program (PRCRP) of the Congressionally Directed Medical Research Programs (CDMRP) has just announced $130 million in funding opportunities for fiscal year 2022.
We use cookies to gather web statistics that help us improve our site. We store no personal details.
OKLearn moreWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, you cannot refuse them without impacting how our site functions. You can block or delete them by changing your browser settings and force blocking all cookies on this website.
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visist to our site you can disable tracking in your browser here:
We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Vimeo and Youtube video embeds:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Privacy Policy